Biohaven
BHVN
218 hedge funds and large institutions have $3.1B invested in Biohaven in 2023 Q4 according to their latest regulatory filings, with 58 funds opening new positions, 77 increasing their positions, 46 reducing their positions, and 26 closing their positions.
225% more call options, than puts
Call options by funds: $31.3M | Put options by funds: $9.63M
123% more first-time investments, than exits
New positions opened: 58 | Existing positions closed: 26
94% more capital invested
Capital invested by funds: $1.6B → $3.1B (+$1.5B)
80% more funds holding in top 10
Funds holding in top 10: 5 → 9 (+4)
67% more repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 46
17% more funds holding
Funds holding: 187 → 218 (+31)
0.27% more ownership
Funds ownership: 89.97% → 90.23% (+0.27%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$47.3M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$45.3M |
| 3 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$33.4M |
| 4 |
PA
Perceptive Advisors
New York
|
+$30.3M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$28.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$41.4M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$26.2M |
| 3 |
Pictet Asset Management
Carouge,
Switzerland
|
-$17.8M |
| 4 |
AC
Armistice Capital
New York
|
-$16.7M |
| 5 |
Holocene Advisors
New York
|
-$16.4M |
BHVN Hedge Fund Activity: Q4 2023 in Review
218 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Biohaven (BHVN) for Q4 2023, worth a combined $3.1B — up 94% from $1.6B a quarter earlier.
Buyers outnumbered sellers: 58 funds opened new BHVN positions and 26 closed out — a net gain of 32 holders — while 77 added to existing stakes and 46 trimmed.
The largest buyer was BlackRock, adding an estimated $47.3M. The largest seller was Fidelity Investments, cutting an estimated $41.4M.
- 218 institutional investors held Biohaven (BHVN) as of Q4 2023, up from 187 in Q3 2023.
- Funds reported $3.1B of Biohaven stock for Q4 2023, up 94% quarter-over-quarter.
- 58 funds opened new Biohaven positions in Q4 2023 and 26 closed out, a net change of +32 holders.
- The largest Biohaven buyer in Q4 2023 was BlackRock, an estimated $47.3M added.
- The largest Biohaven seller in Q4 2023 was Fidelity Investments, an estimated $41.4M sold.
Based on aggregated 13F filings for Q4 2023.